Silverback Therapeutics logo
Silverback Therapeutics SBTX

Quarterly report 2026-Q1
added 05-15-2026

report update icon

Silverback Therapeutics EV/EBITDA Ratio 2011-2026 | SBTX

Annual EV/EBITDA Ratio Silverback Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.966 -14.5 -7.6 -1.19 1.07 -1.06 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.07 -14.5 -4.04